ONEILL ALISON (Chief Medical Officer) sold 32.9% of their position (14.81K shares) of SURFACE ONCOLOGY, INC. on the open market
Open‑market sale worth $90.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/14/2022ACC: 0001209191-22-003395
Officer· Chief Medical Officer
Since Apr 2021
+30.19K
Net shares
Net buyer
$90.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
45K acquired · 14.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
New position
3/1/2020
0.00→45K
Common Stock
Direct
Shares
−14.81K
Price / share
$6.10
Trade value
$90.33K
% of position
32.9%
7/21/2021
45K→30.19K
Total
Net shares
+30.19K
Net value
-$90.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2020 | A · Award | +45K | — | — | New position | 0.00 | 45K |
| Common Stock Direct | 7/21/2021 | S · Sale | −14.81K | $6.10 | $90.33K | 32.9% | 45K | 30.19K |
| Total | +30.19K | -$90.33K | ||||||
Derivative Transactions0
No derivative transactions reported